BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 27502417)

  • 1. Intrinsic HER4/4ICD transcriptional activation domains are required for STAT5A activated gene expression.
    Han W; Sfondouris ME; Semmes EC; Meyer AM; Jones FE
    Gene; 2016 Oct; 592(1):221-226. PubMed ID: 27502417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct coupling of the HER4 intracellular domain (4ICD) and STAT5A signaling is required to induce mammary epithelial cell differentiation.
    Han W; Sfondouris ME; Jones FE
    Biochem Biophys Rep; 2016 Sep; 7():323-327. PubMed ID: 28955922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone.
    Williams CC; Allison JG; Vidal GA; Burow ME; Beckman BS; Marrero L; Jones FE
    J Cell Biol; 2004 Nov; 167(3):469-78. PubMed ID: 15534001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HER4 selectively coregulates estrogen stimulated genes associated with breast tumor cell proliferation.
    Han W; Jones FE
    Biochem Biophys Res Commun; 2014 Jan; 443(2):458-63. PubMed ID: 24333426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presenilin-dependent gamma-secretase processing regulates multiple ERBB4/HER4 activities.
    Vidal GA; Naresh A; Marrero L; Jones FE
    J Biol Chem; 2005 May; 280(20):19777-83. PubMed ID: 15746097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coregulation of estrogen receptor by ERBB4/HER4 establishes a growth-promoting autocrine signal in breast tumor cells.
    Zhu Y; Sullivan LL; Nair SS; Williams CC; Pandey AK; Marrero L; Vadlamudi RK; Jones FE
    Cancer Res; 2006 Aug; 66(16):7991-8. PubMed ID: 16912174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response.
    Pfitzner E; Jähne R; Wissler M; Stoecklin E; Groner B
    Mol Endocrinol; 1998 Oct; 12(10):1582-93. PubMed ID: 9773981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER4 intracellular domain (4ICD) activity in the developing mammary gland and breast cancer.
    Jones FE
    J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):247-58. PubMed ID: 18473151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells.
    Naresh A; Long W; Vidal GA; Wimley WC; Marrero L; Sartor CI; Tovey S; Cooke TG; Bartlett JM; Jones FE
    Cancer Res; 2006 Jun; 66(12):6412-20. PubMed ID: 16778220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells.
    Muraoka-Cook RS; Sandahl M; Husted C; Hunter D; Miraglia L; Feng SM; Elenius K; Earp HS
    Mol Biol Cell; 2006 Sep; 17(9):4118-29. PubMed ID: 16837552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biasing human epidermal growth factor receptor 4 (HER4) tyrosine kinase signaling with antibodies: Induction of cell death by antibody-dependent HER4 intracellular domain trafficking.
    Lanotte R; Garambois V; Gaborit N; Larbouret C; Musnier A; Martineau P; Pèlegrin A; Chardès T
    Cancer Sci; 2020 Jul; 111(7):2508-2525. PubMed ID: 32415868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium.
    Rokicki J; Das PM; Giltnane JM; Wansbury O; Rimm DL; Howard BA; Jones FE
    Mol Cancer; 2010 Jun; 9():150. PubMed ID: 20550710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping C-terminal transactivation domains of the nuclear HER family receptor tyrosine kinase HER3.
    Brand TM; Iida M; Luthar N; Wleklinski MJ; Starr MM; Wheeler DL
    PLoS One; 2013; 8(8):e71518. PubMed ID: 23951180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serine phosphorylation of GH-activated signal transducer and activator of transcription 5a (STAT5a) and STAT5b: impact on STAT5 transcriptional activity.
    Park SH; Yamashita H; Rui H; Waxman DJ
    Mol Endocrinol; 2001 Dec; 15(12):2157-71. PubMed ID: 11731617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
    Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMGN2 inducibly binds a novel transactivation domain in nuclear PRLr to coordinate Stat5a-mediated transcription.
    Fiorillo AA; Medler TR; Feeney YB; Liu Y; Tommerdahl KL; Clevenger CV
    Mol Endocrinol; 2011 Sep; 25(9):1550-64. PubMed ID: 21816901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression level-dependent contribution of glucocorticoid receptor domains for functional interaction with STAT5.
    Doppler W; Windegger M; Soratroi C; Tomasi J; Lechner J; Rusconi S; Cato AC; Almlöf T; Liden J; Okret S; Gustafsson JA; Richard-Foy H; Starr DB; Klocker H; Edwards D; Geymayer S
    Mol Cell Biol; 2001 May; 21(9):3266-79. PubMed ID: 11287629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HER4/4ICD estrogen receptor coactivator and BH3-only protein is an effector of tamoxifen-induced apoptosis.
    Naresh A; Thor AD; Edgerton SM; Torkko KC; Kumar R; Jones FE
    Cancer Res; 2008 Aug; 68(15):6387-95. PubMed ID: 18676864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of a carboxy terminally truncated Stat5 with no transactivation domain in the mammary glands of transgenic mice inhibits cell proliferation during pregnancy, delays onset of milk secretion, and induces apoptosis upon involution.
    Iavnilovitch E; Eilon T; Groner B; Barash I
    Mol Reprod Dev; 2006 Jul; 73(7):841-9. PubMed ID: 16596634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The localization of HER4 intracellular domain and expression of its alternately-spliced isoforms have prognostic significance in ER+ HER2- breast cancer.
    Fujiwara S; Hung M; Yamamoto-Ibusuk CM; Yamamoto Y; Yamamoto S; Tomiguchi M; Takeshita T; Hayashi M; Sueta A; Iwase H
    Oncotarget; 2014 Jun; 5(11):3919-30. PubMed ID: 25003574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.